期刊文献+

IMA对低胆固醇水平的腹膜透析患者心血管事件影响分析

Effect of IMA on cardiovascular events in peritoneal dialysis patients with low level
下载PDF
导出
摘要 目的:评价缺血修饰蛋白(IMA)对腹膜透析(PD)患者主要不良心血管事件(MACE)独立于传统因素外的影响。方法:选取PD治疗>3月的终末期肾病患者108例,按照低密度脂蛋白胆固醇(LDLC)水平分为两组,LDL-C<1.8 mmol/L为试验组,LDL-C≥1.8 mmol/L为对照组,收集患者的基础资料、IMA及各项指标并进行随访,观察MACE的发生情况及IMA对MACE事件的影响。结果:试验组共30例患者,随访期间共6例患者发生MACE事件,对照组78例患者,共13例患者发生MACE事件,两组比较无统计学意义(χ2=0.13,t=0.72);试验组hs-CRP水平较对照组高(4.86±2.38 vs.3.53±1.81,t=2.82,P<0.01);logistic回归分析显示IMA(OR=1.30,95%CI 1.08-1.57)、hs-CRP(OR=1.76,95%CI 1.0-2.97)是PD患者MACE事件的独立危险因素。结论:IMA及hs-CRP是PD患者MACE事件的良好预测指标,且独立于传统危险因素之外;相对于普通患者,氧化应激及炎症状态可能是PD患者心血管事件高发的主要原因。 Objective:To evaluate the effect of ischemic modified protein(IMA) on major adverse cardiovascular events(MACE) in patients with peritoneal dialysis(PD) independent of traditional factors.Methods:108 patients with end-stage renal disease who underwent PD treatment were divided into two groups according to low-density lipoprotein cholesterol(LDL-C),LDL-C1.8 mmol/L for the experimental group,LDL-C≥1.8 mmol/L as the control group.Patient's basic data,IMA and the indicators else were collected and followedup to occurrence of MACE.Results:A total of 30 patients were enrolled in the trial group,and 6 patients developed MACE during follow-up.In the control group,13 patients had a MACE event in 78 patients.There was no significant difference between the two groups(χ~2=0.13,t=0.72).The level of hs-CRP in the test group was higher than that in the control group(4.86±2.38 vs 3.53±1.81,t=2.82,P〈0.01).Logistic regression analysis showed that IMA(OR=1.30,95%CI 1.08-1.57) and hs-CRP(OR=1.76,95%CI 1.0-2.97) were independent risk factors for MACE patients with PD.Conclusion:IMA and hs-CRP are good predictors of MACE events in PD patients and are independent of traditional risk factors.Oxidative stress and inflammatory status may be the main cause of high cardiovascular events in PD patients compared with normal patients.
作者 陈顺华 苏晓燕 黄辉 李恒 赵玉 陈本发 Chen Shunhua;Su Xiaoyan;Huang Hui;Li Heng;Zhao Yu;Chen Ben(Department of Cardiology,Donghua Hospital of Sun Yat-sen University,Dongguan,Guangdong 523110,China;Department of Nephrology,Donghua Hospital of Sun Yat-sen University,Dongguan,Guangdong 523110,China;Department of Cardiology,Sun Yat-sen Memorial Hospital of Sun rat-Sen University,Guangzhou,Guangdong 510120.China)
出处 《广州医科大学学报》 2017年第4期18-22,共5页 Academic Journal of Guangzhou Medical University
基金 广东省医学科研基金(A2016248)
关键词 缺血修饰蛋白 腹膜透析 心血管事件 冠心病 IMA peritoneal dialysis patients cardiovascular events low blood lipid level
  • 相关文献

参考文献4

二级参考文献40

  • 1Schaubel DE,Morrison HI,Fenton SS.Comparing mortality rates on CAPD/CCPD and hemodialysis.The Canadian experience:fact or fiction?Perit Dial Int,1998,18:478-484.
  • 2Vonesh EF,Snyder JJ,Foley RN,et al.The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.Kidney Int,2004,66:2389-2401.
  • 3Liem YS,Wong JB,Hunink MG,et al.Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands.Kidney Int,2007,71:153-158.
  • 4Stephen P,McDonald,Mark R,et al.Relationship between Dialysis Modality and Mortality.J Am Soc Nephrol,2009,20:155-163.
  • 5Mailloux LU,Bellucci AG,Wilkes BM,et al.Mortality in dialysis patients:analysis of the causes of death.Am J Kidney Dis,1991,18(3):326-335.
  • 6Bloembergen WE,Port FK,Mauger EA,et al.A Comparison of Cause of Death Between Patients Treated With Hemodialysis and Peritoneal Dialysis.J Am Soc Nephrol,1995,6:184-191.
  • 7Charlson ME,Pompei P,Ales KL,et al.A new method of classifying prognostic cormorbidity in longitudinal studies:development and validation.J Chronic Dis,1987,40:373-383.
  • 8Fujimoto N,lsekiK,Tokuyama K,et al.Significance of coronary artery calcification score(CACS)for the detection of coronary artery disease(CAD)in chronic dialysis patients.Clin Chim Acta,2006,367:98-102.
  • 9Bradbury BD,Fissell RB,Albert JM,et al.Predictors of Early Mortality among Incident US Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study(DOPPS).Clin J Am Soc Nephrol,2007,2(1):89-99.
  • 10Burke SW,Solomon AJ.Cardiac complications of end stage renal disease.Adv Ren Repace Ther,2000,7(3):210-219.

共引文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部